Inti Zlobec
About
Inti Zlobec is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology.
According to data from OpenAlex, Inti Zlobec has authored 276 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Oncology, 85 papers in Pathology and Forensic Medicine and 64 papers in Molecular Biology. Recurrent topics in Inti Zlobec's work include Genetic factors in colorectal cancer (77 papers), Colorectal Cancer Treatments and Studies (58 papers) and Colorectal Cancer Surgical Treatments (57 papers). Inti Zlobec is often cited by papers focused on Genetic factors in colorectal cancer (77 papers), Colorectal Cancer Treatments and Studies (58 papers) and Colorectal Cancer Surgical Treatments (57 papers). Inti Zlobec collaborates with scholars based in Switzerland, United States and Canada. Inti Zlobec's co-authors include Alessandro Lugli, Luigi Terracciano, Eva Karamitopoulou, Luigi Tornillo, Viktor H. Koelzer, Jeremy R. Jass, Kristi Baker, Heather Dawson, Andrea Kopp Lugli and Martin D. Berger and has published in prestigious journals such as Nature, Science and Cell.
In The Last Decade
Inti Zlobec
263 papers receiving 11.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Inti Zlobec Switzerland | 62 | 6.9k | 3.7k | 2.5k | 2.1k | 2.0k | 276 | 12.0k | ||
| Alessandro Lugli Switzerland | 56 | 6.1k 0.9× | 2.5k 0.7× | 2.4k 0.9× | 1.7k 0.8× | 1.4k 0.7× | 214 | 9.7k | ||
| Frédéric Bibeau France | 49 | 6.3k 0.9× | 3.3k 0.9× | 2.5k 1.0× | 2.4k 1.1× | 888 0.4× | 193 | 10.7k | ||
| C. Blake Gilks Canada | 63 | 5.0k 0.7× | 4.2k 1.1× | 2.3k 0.9× | 2.3k 1.1× | 1.9k 1.0× | 179 | 14.3k | ||
| Sarina A. Piha‐Paul United States | 53 | 9.3k 1.4× | 4.0k 1.1× | 1.7k 0.7× | 4.2k 2.0× | 2.9k 1.4× | 432 | 14.7k | ||
| Bart Neyns Belgium | 53 | 9.8k 1.4× | 4.2k 1.2× | 1.6k 0.6× | 2.6k 1.2× | 4.4k 2.2× | 316 | 13.9k | ||
| Timothy J. Yeatman United States | 56 | 5.1k 0.7× | 5.9k 1.6× | 2.1k 0.9× | 1.6k 0.8× | 932 0.5× | 169 | 11.8k | ||
| Karin Jirström Sweden | 59 | 6.2k 0.9× | 5.9k 1.6× | 1.3k 0.5× | 2.1k 1.0× | 3.0k 1.5× | 316 | 13.3k | ||
| Sunil Badve United States | 59 | 6.4k 0.9× | 5.5k 1.5× | 1.5k 0.6× | 2.0k 0.9× | 1.3k 0.7× | 309 | 14.3k | ||
| Nobuyoshi Hiraoka Japan | 55 | 5.7k 0.8× | 3.7k 1.0× | 1.1k 0.4× | 2.0k 1.0× | 3.1k 1.5× | 242 | 11.3k | ||
| Vincent T.H.B.M. Smit Netherlands | 56 | 3.8k 0.5× | 2.7k 0.7× | 1.8k 0.7× | 1.8k 0.9× | 1.0k 0.5× | 200 | 12.0k |
Countries citing papers authored by Inti Zlobec
Since
Specialization
Citations
This map shows the geographic impact of Inti Zlobec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inti Zlobec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inti Zlobec more than expected).
Fields of papers citing papers by Inti Zlobec
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Inti Zlobec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inti Zlobec. The network helps show where Inti Zlobec may publish in the future.
Co-authorship network of co-authors of Inti Zlobec
This figure shows the co-authorship network connecting the top 25 collaborators of Inti Zlobec. A scholar is included among the top collaborators of Inti Zlobec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inti Zlobec. Inti Zlobec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bokhorst, John‐Melle, Martin D. Berger, Femke Simmer, et al.. (2024). Combining immunoscore and tumor budding in colon cancer: an insightful prognostication based on the tumor-host interface. Journal of Translational Medicine. 22(1). 1090–1090.
2.
Neto, Pedro C., Diana Montezuma, João Monteiro, et al.. (2024). An interpretable machine learning system for colorectal cancer diagnosis from pathology slides. npj Precision Oncology. 8(1). 56–56.
3.
Lu, Benjamin Y., et al.. (2023). Beyond the Lab and Into the Hospital: An Outlook on the Clinical Utility of Spatial Omics Technologies. 2(5). 360–371.
4.
Bellanger, Anne‐Pauline, Junhua Wang, Houssein Gbaguidi‐Haore, et al.. (2021). Investigating new serological and tissue markers for the follow‐up of patients operated for alveolar echinococcosis. Parasite Immunology. 43(6). e12827–e12827.
5.
Kandasamy, Palanivel, Inti Zlobec, Jonai Pujol‐Giménez, et al.. (2021). Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1. Molecular Oncology. 15(10). 2782–2800.
6.
Fischer, Andreas, et al.. (2021). Self-Rule to Adapt: Learning Generalized Features from Sparsely-Labeled Data Using Unsupervised Domain Adaptation for Colorectal Cancer Tissue Phenotyping. ArODES (HES-SO (https://www.hes-so.ch/)). 5–21.
7.
Blank, Annika, John‐Melle Bokhorst, Irıs D. Nagtegaal, et al.. (2020). Taking tumour budding to the next frontier — a post International Tumour Budding Consensus Conference (ITBCC) 2016 review. Histopathology. 78(4). 476–484.
8.
Neppl, Christina, Inti Zlobec, Ralph A. Schmid, & Sabina Berezowska. (2019). Validation of the International Tumor Budding Consensus Conference (ITBCC) 2016 recommendation in squamous cell carcinoma of the lung—a single-center analysis of 354 cases. Modern Pathology. 33(5). 802–811.
9.
Zlobec, Inti, et al.. (2019). Graph-based classification of intestinal glands in colorectal cancer tissue images. ArODES (HES-SO (https://www.hes-so.ch/)).
10.
Liu, He, Zhaoyue He, Nina Germič, et al.. (2019). ATG12 deficiency leads to tumor cell oncosis owing to diminished mitochondrial biogenesis and reduced cellular bioenergetics. Cell Death and Differentiation. 27(6). 1965–1980.
11.
Kröll, Dino, Federico Storni, Bastian Dislich, et al.. (2018). Application of the 8th edition of the AJCC yTNM staging system shows improved prognostication in a single center cohort of esophageal carcinomas. Surgical Oncology. 27(1). 100–105.
12.
Dawson, Heather, Alexander Novotny, Karen Becker, et al.. (2016). Macroscopy predicts tumor progression in gastric cancer: A retrospective patho-historical analysis based on Napoleon Bonaparte's autopsy report. Digestive and Liver Disease. 48(11). 1378–1385.
13.
Riether, Carsten, Christian M. Schürch, Magdalena Hinterbrandner, et al.. (2016). CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia. The Journal of Experimental Medicine. 214(2). 359–380.
14.
Zlobec, Inti, K Dirschmid, Felix Offner, et al.. (2014). A multicentre inter-observer study on tumour budding using a 10HPF method in colorectal cancer: a study from the Swiss Association of Gastrointestinal Pathology (SAGIP). Bern Open Repository and Information System (University of Bern).
15.
Zlobec, Inti, et al.. (2013). Immunohistochemistry Helps To Discriminate between Symplastic Leiomyoma and Leiomyosarcoma of the Uterus. Bern Open Repository and Information System (University of Bern).
16.
Ghosal, Abhisek, Lucia Buccarello, Carlos Wotzkow, et al.. (2012). RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance. Oncogene. 32(34). 3944–3953.
17.
Lugli, Alessandro, Tatjana Vlajnic, Olivier Giger, et al.. (2011). Intratumoral budding as a potential parameter of tumor progression in mismatch repair–proficient and mismatch repair–deficient colorectal cancer patients. Human Pathology. 42(12). 1833–1840.
18.
Simonetti, S., Luigi Terracciano, Inti Zlobec, et al.. (2011). Immunophenotyping analysis in invasive micropapillary carcinoma of the breast: Role of CD24 and CD44 isoforms expression. The Breast. 21(2). 165–170.
19.
Zlobec, Inti, Luigi Terracciano, Jeremy R. Jass, & Alessandro Lugli. (2007). Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 451(4). 763–769.
20.
Zlobec, Inti, T. Vuong, & Carolyn C. Compton. (2005). The predictive value of apoptosis protease‐activating factor 1 in rectal tumors treated with preoperative, high‐dose‐rate brachytherapy. Cancer. 106(2). 284–286.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Alessandro Lugli Breakdown of academic impact, for papers by Frédéric Bibeau Breakdown of academic impact, for papers by C. Blake Gilks Breakdown of academic impact, for papers by Sarina A. Piha‐Paul Breakdown of academic impact, for papers by Bart Neyns Breakdown of academic impact, for papers by Timothy J. Yeatman Breakdown of academic impact, for papers by Karin Jirström Breakdown of academic impact, for papers by Sunil Badve Breakdown of academic impact, for papers by Nobuyoshi Hiraoka Breakdown of academic impact, for papers by Vincent T.H.B.M. Smit